X

Trial Profile

Double-Blind, Placebo-Controlled Comparative Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 21 Nov 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fentanyl (Primary)
Indications Postoperative pain
Focus Therapeutic Use
Sponsors SymBio Pharmaceuticals

Most Recent Events

09 Feb 2018 According to a SymBio Pharmaceuticals media release, the company announced today the completion of the termination of the development of IONSYS or SyB P-1501 in Japan.
09 Feb 2018 Status changed from recruiting to discontinued, according to a SymBio Pharmaceuticals media release.
16 Jun 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com